Envestnet Asset Management Inc. Has $12.95 Million Position in Astera Labs, Inc. $ALAB

Envestnet Asset Management Inc. cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 25.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,146 shares of the company’s stock after selling 22,047 shares during the period. Envestnet Asset Management Inc.’s holdings in Astera Labs were worth $12,951,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in ALAB. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Astera Labs by 21.6% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after buying an additional 2,624 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock worth $9,908,000 after acquiring an additional 53,276 shares during the period. Vanguard Personalized Indexing Management LLC raised its position in Astera Labs by 142.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company’s stock valued at $1,028,000 after acquiring an additional 6,677 shares in the last quarter. Harbour Investments Inc. lifted its stake in shares of Astera Labs by 207.7% in the 2nd quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock valued at $221,000 after purchasing an additional 1,651 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in Astera Labs by 34.5% during the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after buying an additional 133,961 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ALAB shares. Roth Mkm lifted their price target on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Needham & Company LLC increased their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. BNP Paribas Exane began coverage on shares of Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating on the stock. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Finally, Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $192.89.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the transaction, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 12.50% of the stock is owned by corporate insiders.

Astera Labs Stock Performance

Astera Labs stock opened at $129.32 on Tuesday. The company has a market capitalization of $21.84 billion, a P/E ratio of 106.00, a PEG ratio of 2.54 and a beta of 1.51. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a 50-day simple moving average of $163.16 and a 200-day simple moving average of $174.78.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the previous year, the company posted $0.37 EPS. Astera Labs’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.